Alkermes Inc. plc (ALKS)
Health Care ยท Pharmaceutical Preparations
Alkermes Inc. plc (ALKS) is listed on Nasdaq, where its shares have traded since July 16, 1991. SentiSense covers Alkermes Inc. plc in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. Blair C. Jackson is its chief executive officer. The company reports 2,050 employees, and its corporate website is www.alkermes.com.
About Alkermes Inc. plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Latest reported results
Alkermes plc reported revenue of $480.1 million for Q3 FY2026, up 21.8% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 410 institutions reported holding ALKS, with 177.1 million shares worth $9.3 billion in aggregate. The largest reported holders were BlackRock, Vanguard and Baker Bros. Advisors. Of the 5 largest reported holders, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
More on ALKS
- ALKS sentiment: whether news and social coverage of Alkermes Inc. plc leans bullish or bearish, and the stories driving it.
- ALKS ownership: all 410 reporting institutions, plus insider and congressional trades.
- ALKS financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
Frequently asked questions
What does Alkermes Inc. plc do?
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas.
What sector is ALKS in?
SentiSense classifies Alkermes Inc. plc in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does ALKS stock trade?
Alkermes Inc. plc (ALKS) is listed on Nasdaq, where its shares have traded since July 16, 1991.
Who is the CEO of Alkermes Inc. plc?
Blair C. Jackson is the chief executive officer of Alkermes Inc. plc.